ABVX ABIVAX Société Anonyme
$91.06
ABIVAX Société Anonyme (ABVX) Earnings News
Earnings press releases, previews and reviews for ABIVAX Société Anonyme (ABVX), newest first. Our most recent is preview: Abivax Faces a Sentiment Test as Wall Street Turns Cautious Ahead of Q3 Report.
Monday
September 21, 2026
4:05 PM ET
Abivax Presents Business Updates and First Half 2026 Financial Results
Sunday
September 13, 2026
10:15 AM ET
Abivax Faces a Sentiment Test as Wall Street Turns Cautious Ahead of Q3 Report
Earnings Whispers · Preview
Monday
July 6, 2026
4:05 PM ET
Abivax Announces Closing of $920 Million Public Offering
Wednesday
July 1, 2026
9:06 AM ET
Correction: Abivax Announces Pricing of Highly Oversubscribed and Upsized $800M (€702M) Public Offering of American Depositary Shares
Wednesday
July 1, 2026
8:36 AM ET
Abivax Announces Pricing of Oversubscribed and Upsized $800M (€702M) Public Offering of American Depositary Shares
Friday
May 22, 2026
4:05 PM ET
Abivax Presents First Quarter 2026 Financial Results and Reports Three-Year Interim Data from Study 108, a Phase 2a/2b Open-Label Extension Trial of Obefazimod Following Dose De-Escalation in Patients with Ulcerative Colitis